Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 [Phase 1]

View source ↗

Summary

Phase 1 study to assess the safety, tolerability and pharmacokinetics of ABY-035; the trial was completed, including both psoriasis patients and healthy subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ABY-035 (ABY-035)

Snippet

Sponsor: Affibody | Conditions: Psoriasis, Healthy Subjects | Phase 1 | Status: COMPLETED